Intrathecal Drug Delivery of Antisense Oligonucleotides in Huntington's Disease: Experience of Ionis/Roche RG6042 Development Programme and Best Practice Considerations for Real-World Use (2019)

First Author: Leavitt Blair R.

Attributed to: MICA: HD-CSF: Studying cerebrospinal fluid to understand key CNS pathobiological targets in Huntington's disease funded by MRC

No abstract provided

Type: Conference/Paper/Proceeding/Abstract

Volume: 16

Parent Publication: NEUROTHERAPEUTICS

Issue: 4

ISSN: 1933-7213